Visualitza per autor "Peters, S."
Ara mostrant els elements 1-3 d 3
-
Atezolizumab versus chemotherapy in advanced or metastatic NSCLC with high blood-based tumor mutational burden: primary analysis of BFAST cohort C randomized phase 3 trial
Peters, S.; Dziadziuszko, Rafal; Morabito, Alessandro; Felip Font, Enriqueta; Cheema, Parneet; Gadgeel, Shirish (Springer Nature, 2022-09) -
ESMO pays tribute to Professor José Baselga
Peters, S.; Tabernero Caturla, Josep; Giuliani, Rosa; Lordick, F.; Banerjee, Susana; Cervantes, Andrés (Elsevier, 2021-07) -
Nivolumab and Ipilimumab as Maintenance Therapy in Extensive-Disease Small-Cell Lung Cancer: CheckMate 451
Owonikoko, Taofeek; Park, Keunchil; Govindan, Ramaswamy; Ready, Neal; Reck, M.; Peters, S.; Navarro Mendivil, Alejandro (Lippincott Williams & Wilkins, 2021-04-20)